
Feature|Videos|February 19, 2025
Accelerate Inclusive Enrollment and Delivery with Lightship
Author(s)Lightship
David MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.
Lightship focuses on patient accessibility and centricity in clinical trials, ensuring the patient experience is a positive one. Learn more about:
- Lightship's impact on achieving diversity in clinical trials by engaging underrepresented patient populations
- How Lightship utilizes hybrid and decentralized trial designs to reduce patient burden
- The impact a patient centric model has on clinical trial participation and outcomes
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Reducing Site Burden Through Better Technology Integration in Clinical Trials
5






.png)



.png)



.png)
.png)
